Mediclinic has rebuffed a £2bn takeover offer from a group of investors that includes its biggest shareholder, Remgro, with its shares having their best day in about eight months as equity traders bet that the Johann Rupert-chaired investment heavyweight is likely to return with a higher bid.
Along with shipping company MSC, in late May, Remgro offered 463p a share for the 55.4% it does not already own in SA’s most valuable hospital group, which is also listed in London...A subscription helps you enjoy the best of our business content every day along with benefits such as articles from our international business news partners; ProfileData financial data; and digital access to the Sunday Times and Sunday Times Daily.
대한민국 최근 뉴스, 대한민국 헤드 라인
Similar News:다른 뉴스 소스에서 수집한 이와 유사한 뉴스 기사를 읽을 수도 있습니다.
Market welcomes Mediclinic’s rejection of £2bn takeover offerEquity traders bet the Regro-led consortium is likely to return with a higher bid
더 많은 것을 읽으십시오 »
Market welcomes Mediclinic’s rejection of £2bn takeover offerEquity traders bet the Remgro-led consortium is likely to return with a higher bid Remgro is Rupert neh?
더 많은 것을 읽으십시오 »
Market Watcher: The highs and lows[MARKET WATCHER] Viv Govender of Rand Swiss takes us through the day’s market developments, the ECB’s meeting outcomes, China’s crackdown on online gaming, and Mediclinic rejecting a takeover bid. MoneywebNews MoneywebRadio Podcasts
더 많은 것을 읽으십시오 »
Market Watcher: So you had a bad day …[MARKET WATCHER] Sasfin’s David Shapiro on the global markets’ downward march, Napsers/Prosus share jump, expected US inflation data, and where to from here for the oil price. MoneywebNews
더 많은 것을 읽으십시오 »